Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS

P. Mertsch (Munich, Germany), I. Pink (Hannover, Germany), J. Rademacher (Hannover, Germany), A. De Roux (Berlin, Germany), S. Konwert (Hannover, Germany), R. Diel (Großhansdorf, Germany), G. Barten (Hannover, Germany), A. Zurawski (Hannover, Germany), T. Welte (Hannover, Germany), J. Behr (Munich, Germany), F. Ringshausen (Hannover, Germany)

Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Session: Non-tuberculous mycobacterial infections and bronchiectasis
Session type: E-poster session
Number: 2366
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Mertsch (Munich, Germany), I. Pink (Hannover, Germany), J. Rademacher (Hannover, Germany), A. De Roux (Berlin, Germany), S. Konwert (Hannover, Germany), R. Diel (Großhansdorf, Germany), G. Barten (Hannover, Germany), A. Zurawski (Hannover, Germany), T. Welte (Hannover, Germany), J. Behr (Munich, Germany), F. Ringshausen (Hannover, Germany). Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS. 2366

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for new P. aeruginosa isolation in bronchiectasis- data from the European Bronchiectasis Registry (EMBARC)
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019

Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Late Breaking Abstract - The prevalence and burden of Pseudomonas aeruginosa among bronchiectasis patients in Europe- data from the FRIENDS cohort
Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections
Year: 2017



Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Year: 2014

Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


PROGNOSIS - the German Bronchiectasis Registry: first results
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis- Guideline and clinical routine
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia in Portuguese Adults: A single-center retrospective study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Phenotyping of adult patients with bronchiectasis and Yellow-Nail-Syndrome (YNS)- data from the German and the European Bronchiectasis Registries (PROGNOSIS and EMBARC)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


Antimicrobial susceptibility of stenotrophomonas maltophilia isolated from respiratory specimens from a tertiary care center in Pakistan
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Pseudomonas aeruginosa DNA-fingerprinting register in Belgian CF-patients: a one year survey
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004

Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Source: Eur Respir J 2006 Oct 01;28(4):740-747
Year: 2006



Emerging macrolide-resistant mycoplasma pneumoniae in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020


Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Pseudomonas aeruginosa colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006


Eradication of Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2006; 27: 438-439
Year: 2006


The prevalence of antimicrobial resistance of P. aeruginosa, K. pneumoniae, E. coli, A. baumanii in Ukraine
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014